| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Thérapies Ciblées
Extract
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy.
Scientific Abstract
en cours d'intégration;